For the quarter ending 2025-09-30, VTYX has $211,465K in assets. $20,101K in debts. $31,970K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 31,970 | 32,301 | ||
| Marketable securities | 160,668 | 176,658 | ||
| Prepaid expenses and other assets | 8,456 | 10,363 | ||
| Total current assets | 201,094 | 219,322 | ||
| Property and equipment, gross | 1,106 | - | ||
| Less accumulated depreciation | 605 | - | ||
| Property and equipment, net | 501 | 549 | ||
| Operating lease right-of-use assets | 8,883 | 9,151 | ||
| Restricted cash | 975 | 975 | ||
| Other long-term assets | 12 | 12 | ||
| Total assets | 211,465 | 230,009 | ||
| Accounts payable | 993 | 913 | ||
| Accrued expenses | 9,084 | 9,418 | ||
| Current portion of operating lease liabilities | 1,182 | 1,138 | ||
| Total current liabilities | 11,259 | 11,469 | ||
| Operating lease liabilities, net of current portion | 8,842 | 9,157 | ||
| Total liabilities | 20,101 | 20,626 | ||
| Common stock, 0.0001 par value 900,000,000 shares authorized at september 30, 2025 and december 31, 2024 71,336,958 and 71,130,054 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 7 | 7 | ||
| Additional paid-in capital | 822,699 | 817,864 | ||
| Accumulated other comprehensive income | 223 | 248 | ||
| Accumulated deficit | -631,565 | -608,736 | ||
| Total stockholders' equity | 191,364 | 209,383 | ||
| Total liabilities and stockholders' equity | 211,465 | 230,009 | ||
Ventyx Biosciences, Inc. (VTYX)
Ventyx Biosciences, Inc. (VTYX)